(Q39567401)

13 September 2017

1 reference

title

Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations (English)

1 reference

13 September 2017

1 reference

M Y Dawood

1

1 reference

13 September 2017

publication date

1 July 1981

1 reference

13 September 2017

1 reference

13 September 2017

volume

22

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

42-56

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198122010-00003

13 September 2017

exact match

0 references

cites work

Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices.

1 reference

12 December 2020

Severe, primary dysmenorrhea treated with naproxen. A prospective, double-blind, crossover investigation

1 reference

12 December 2020

Prostaglandin Synthetase Inhibitors and Dysmenorrhea: A Survey and Personal Clinical Experience

1 reference

12 December 2020

Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study

1 reference

12 December 2020

Prostaglandins in primary dysmenorrhea. Comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives

1 reference

12 December 2020

Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women

1 reference

12 December 2020

The relief of primary dysmenorrhea by ketoprofen and indomethacin

1 reference

12 December 2020

Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea

1 reference

12 December 2020

Treatment of Primary Dysmenorrhea with Prostaglandin Synthetase Inhibitors—a Promising Therapeutic Alternative

1 reference

12 December 2020

New concepts in dysmenorrhea

1 reference

12 December 2020

Primary dysmenorrhoea treated with indomethacin

1 reference

12 December 2020

The treatment of dysmenorrhea with naproxen sodium: a report on two independent double-blind trials

1 reference

12 December 2020

Naproxen and Indomethacin in the Treatment of Primary Dysmenorrhea

1 reference

12 December 2020

Effect of Acetylsalicylic Acid, Paracetamol and Placebo on Pain and Blood Loss in Dysmenorrheic Women

1 reference

12 December 2020

Clinical Experience of Naproxen in the Treatment of Primary Dysmenorrhea

1 reference

12 December 2020

Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy

1 reference

12 December 2020

Studies in the involvement of prostaglandins in uterine symptomatology and pathology

1 reference

12 December 2020

Ibuprofen therapy for dysmenorrhea

1 reference

12 December 2020

Levels of prostaglandins in human endometrium during the normal menstrual cycle

1 reference

12 December 2020

Use of Mefenamic Acid in the Treatment of Primary Dysmenorrhea

1 reference

12 December 2020

Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors

1 reference

12 December 2020

Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid

1 reference

12 December 2020

Dysmenorrhea: treatment with an antiprostaglandin

1 reference

12 December 2020

Levels of prostaglandins F2α and E2 in human endometrium during the menstrual cycle

1 reference

12 December 2020

Naproxen and Naproxen Sodium in Dysmenorrhea: Development from in vitro Inhibition of Prostaglandin Synthesis to Suppression of Uterine Contractions in Women and Demonstration of Clinical Efficacy

1 reference

12 December 2020

10.2165/00003495-198122010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

13 September 2017

1014698513

0 references

1 reference